These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 27894872)

  • 1. Synthesis, screening and docking analysis of hispolon analogs as potential antitubercular agents.
    Balaji NV; Hari Babu B; Subbaraju GV; Purna Nagasree K; Murali Krishna Kumar M
    Bioorg Med Chem Lett; 2017 Jan; 27(1):11-15. PubMed ID: 27894872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, Screening and Docking Analysis of Hispolon Pyrazoles and Isoxazoles as Potential Antitubercular Agents.
    Balaji NV; HariBabu B; Rao VU; Subbaraju GV; Nagasree KP; Kumar MMK
    Curr Top Med Chem; 2019; 19(9):662-682. PubMed ID: 30834836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New INH-pyrazole analogs: Design, synthesis and evaluation of antitubercular and antibacterial activity.
    Nayak N; Ramprasad J; Dalimba U
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5540-5. PubMed ID: 26520663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids.
    Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
    Bioorg Med Chem Lett; 2014 Jan; 24(1):233-6. PubMed ID: 24314670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MoS
    Raghu MS; Pradeep Kumar CB; Prasad KNN; Prashanth MK; Kumarswamy YK; Chandrasekhar S; Veeresh B
    ACS Comb Sci; 2020 Oct; 22(10):509-518. PubMed ID: 32806898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, biological evaluation and structure-activity relationship of 2-styrylquinazolones as anti-tubercular agents.
    Jadhavar PS; Dhameliya TM; Vaja MD; Kumar D; Sridevi JP; Yogeeswari P; Sriram D; Chakraborti AK
    Bioorg Med Chem Lett; 2016 Jun; 26(11):2663-9. PubMed ID: 27095514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, docking analysis, identification, and synthesis of novel 3-(((substituted phenyl) amino)methyl)-2-methylquinazolin-4(3H)-one compounds to fight tuberculosis.
    Panneerselvam T; Sivakumar A; Arumugam S; Joshi SD
    Drug Discov Ther; 2016; 10(4):188-94. PubMed ID: 27594295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzo[d]thiazole-2-carbanilides as new anti-TB chemotypes: Design, synthesis, biological evaluation, and structure-activity relationship.
    Dhameliya TM; Tiwari R; Banerjee A; Pancholia S; Sriram D; Panda D; Chakraborti AK
    Eur J Med Chem; 2018 Jul; 155():364-380. PubMed ID: 29902722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, Synthesis, and Characterization of Some Hybridized Pyrazolone Pharmacophore Analogs against Mycobacterium tuberculosis.
    Krishnasamy SK; Namasivayam V; Mathew S; Eakambaram RS; Ibrahim IA; Natarajan A; Palaniappan S
    Arch Pharm (Weinheim); 2016 May; 349(5):383-97. PubMed ID: 27135906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A green expedient synthesis of pyridopyrimidine-2-thiones and their antitubercular activity.
    Rajesh SM; Kumar RS; Libertsen LA; Perumal S; Yogeeswari P; Sriram D
    Bioorg Med Chem Lett; 2011 May; 21(10):3012-6. PubMed ID: 21498077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity.
    Martins F; Santos S; Ventura C; Elvas-Leitão R; Santos L; Vitorino S; Reis M; Miranda V; Correia HF; Aires-de-Sousa J; Kovalishyn V; Latino DA; Ramos J; Viveiros M
    Eur J Med Chem; 2014 Jun; 81():119-38. PubMed ID: 24836065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A convenient synthesis and screening of benzosuberone bearing 1,2,3-triazoles against Mycobacterium tuberculosis.
    Sajja Y; Vanguru S; Jilla L; Vulupala HR; Bantu R; Yogeswari P; Sriram D; Nagarapu L
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4292-5. PubMed ID: 27476139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microwave-assisted synthesis, molecular docking and antitubercular activity of 1,2,3,4-tetrahydropyrimidine-5-carbonitrile derivatives.
    Mohan SB; Ravi Kumar BV; Dinda SC; Naik D; Prabu Seenivasan S; Kumar V; Rana DN; Brahmkshatriya PS
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7539-42. PubMed ID: 23122523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents.
    Desai NC; Somani H; Trivedi A; Bhatt K; Nawale L; Khedkar VM; Jha PC; Sarkar D
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1776-83. PubMed ID: 26920799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based design of some isonicotinic acid hydrazide analogues as potential antitubercular agents.
    Atta A; Fahmy S; Rizk O; Sriram D; Mahran MA; Labouta IM
    Bioorg Chem; 2018 Oct; 80():721-732. PubMed ID: 30077175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.
    Rani C; Mehra R; Sharma R; Chib R; Wazir P; Nargotra A; Khan IA
    Tuberculosis (Edinb); 2015 Dec; 95(6):664-677. PubMed ID: 26318557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of new phenothiazine-thiadiazole hybrids via molecular hybridization approach for the development of potent antitubercular agents.
    Ramprasad J; Nayak N; Dalimba U
    Eur J Med Chem; 2015 Dec; 106():75-84. PubMed ID: 26520841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of 11α-substituted bile acid derivatives as potential anti-tuberculosis agents.
    Pore VS; Divse JM; Charolkar CR; Nawale LU; Khedkar VM; Sarkar D
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4185-90. PubMed ID: 26299346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.